Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.086 EUR | -0.29% |
|
-1.11% | +74.32% |
Jun. 27 | Hansa Biopharma AB Announces Board Appointments | CI |
May. 31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock
- Charts Hansa Biopharma AB